Q2 2025 Holdings
Filed 2025-08-14 | 37 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $288.3M | 22,970,388 | 17.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $205.9M | 11,895,808 | 12.2% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $181.1M | 1,706,469 | 10.7% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $174.9M | 7,880,094 | 10.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $123.3M | 4,288,120 | 7.3% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $106.6M | 10,688,978 | 6.3% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $67.6M | 1,389,276 | 4.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $55.6M | 3,988,971 | 3.3% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $54.4M | 10,630,736 | 3.2% |
| Xencor Inc(XNCR) | COM | 98401F105 | $48.3M | 6,144,767 | 2.9% |
| Immunome Inc(IMNM) | COM | 45257U108 | $37.9M | 4,079,415 | 2.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $34.0M | 1,469,818 | 2.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $29.0M | 1,036,945 | 1.7% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $28.9M | 2,030,544 | 1.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $24.2M | 4,200,000 | 1.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $23.5M | 440,000 | 1.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $22.7M | 75,000 | 1.3% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $19.0M | 1,271,342 | 1.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $18.9M | 200,000 | 1.1% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $18.6M | 935,121 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $16.4M | 1,618,068 | 1.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $14.3M | 500,000 | 0.8% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $14.2M | 500,000 | 0.8% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $13.1M | 1,149,794 | 0.8% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $12.2M | 3,917,546 | 0.7% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $10.9M | 457,471 | 0.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $7.9M | 850,341 | 0.5% |
| Metsera Inc | COM | 59267L107 | $7.7M | 271,529 | 0.5% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADS | 00653A107 | $6.6M | 27,404,070 | 0.4% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $5.6M | 862,068 | 0.3% |
| Hillevax Inc | COM | 43157M102 | $4.8M | 2,420,243 | 0.3% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $4.4M | 573,183 | 0.3% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $2.0M | 1,091,417 | 0.1% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $1.9M | 1,602,717 | 0.1% |
| Uniqure NV(QURE)Call | SHS | N90064101 | $1.9M | 135,000 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $1.9M | 963,333 | 0.1% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $596.0K | 66,665 | 0.0% |